Press Releases

Flagship Pioneering and its portfolio companies make news because of their transformative approaches to solving global challenges. If you have needs beyond these resources, please contact press@flagshippioneering.com.

company

year

domain

Flagship Pioneering Announces Appointment of Tuyen Ong as CEO-Partner

Ring Therapeutics 10.13.2020

Kaleido Biosciences Appoints Daniel Menichella as President and Chief Executive Officer

Kaleido Biosciences 10.01.2020

Flagship Pioneering Announces Valo Health to Transform Drug Development

Valo 09.23.2020

Cygnal Therapeutics Expands Leadership Team With Appointment Of John A. Wagner, M.D., Ph.D., As Chief Medical Officer

Cygnal Therapeutics 09.16.2020

Flagship Pioneering’s Scientists Invent Machine Learning–Powered Platform to Generate Novel Biomedicines

Generate Biomedicines 09.09.2020

Seres Therapeutics Announces Positive Topline Results From SER-109 Phase 3 ECOSPOR III Study In Recurrent C. Difficile Infection

Seres Therapeutics 08.13.2020

Omega Therapeutics Advances Controllable Epigenomic Programming Platform to Deliver a Pipeline of Novel Therapeutics with $85M in Financing

Omega Therapeutics 07.29.2020

Flagship Pioneering’s Scientists Invent a New Category of Genome Engineering Technology: Gene Writing

Tessera Therapeutics 07.07.2020

Flagship Pioneering Bolsters Executive Team with Appointment of Fabrice Chouraqui in Newly Created Dual Role of Flagship CEO-Partner and CEO of Cellarity

Cellarity 05.28.2020

Moderna Announces Positive Interim Phase 1 Data for its mRNA Vaccine (mRNA-1273) Against Novel Coronavirus

Moderna 05.18.2020

Loading